Development
Evaxion Biotech A/S
EVAX
$3.13
$0.5521.32%
NASDAQ
| 09/30/2023 | 12/31/2022 | 09/30/2022 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -63.40% | -- | -- | ||
| Total Receivables | -14.83% | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 0.54% | -- | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | -39.71% | -- | -- | ||
|
|
|||||
| Total Current Assets | -39.71% | -- | -- | ||
| Net Property, Plant & Equipment | -5.91% | -- | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -3.36% | -- | -- | ||
| Total Assets | -28.72% | -- | -- | ||
|
|
|||||
| Total Accounts Payable | 54.78% | -- | -- | ||
| Total Accrued Expenses | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -1.91% | -- | -- | ||
| Total Finance Division Other Current Liabilities | -14.56% | -- | -- | ||
| Total Other Current Liabilities | -14.56% | -- | -- | ||
| Total Current Liabilities | 15.75% | -- | -- | ||
|
|
|||||
| Total Current Liabilities | 15.75% | -- | -- | ||
| Long-Term Debt | -1.08% | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -4.62% | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -2.72% | -- | -- | ||
| Total Liabilities | 3.21% | -- | -- | ||
|
|
|||||
| Common Stock & APIC | 0.17% | -- | -- | ||
| Retained Earnings | -6.53% | -- | -- | ||
| Treasury Stock & Other | 2.40% | -- | -- | ||
| Total Common Equity | -207.85% | -- | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | -207.85% | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -207.85% | -- | -- | ||
|
|
|||||